The Human Element
The challenges of using biomarkers to predict the health impact of e-cigarettes and heat-not-burn products.
Charlotte Barker |
At a Glance
- Biomarkers in the context of e-cigarettes and similar smoking alternatives have thus far not been well-studied
- Previous studies have focused on biomarkers with little link to long-term health or do not reflect the ways people actually use e-cigarettes
- Some components of e-cigarette fluids, like formaldehyde, have no useful exposure biomarkers at all
- To identify reliable biomarkers for monitoring ongoing health, the field needs long-term investigation of people who use smoking alternatives
Lion Shahab is a psychologist, neuroscientist and epidemiologist, with a focus on tobacco control: “My interest is in the use of biomarkers as a tool to motivate smoking cessation and investigate the effects of tobacco products and products such as e-cigarettes that are thought to mitigate harms.
“Around 2011, people started approaching our group at University College London about e-cigarettes, which were just taking off at the time,” says Shahab. Based on his previous biomarker work, he secured funding from Cancer Research UK for a study examining biomarkers related to various negative health outcomes in users of e-cigarettes compared with smokers, and those using nicotine replacement therapy, such as gum and patches (1).
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine